Rokaya El Ansari

The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours

Rokaya El Ansari, Madeleine L. Craze, Islam M. Miligy et al. · Breast Cancer Research · 2018 · 142 citations · Full text

Medicine, Molecular Biology, Oncology +17

Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer

Matteo Morotti, Christos E. Zois, Rokaya El Ansari et al. · British Journal of Cancer · 2020 · 132 citations · Full text

Medicine, Oncology, Cancer Pharmacology +5

MYC regulation of glutamine–proline regulatory axis is key in luminal B breast cancer

Madeleine L. Craze, Hayley Cheung, Natasha Jewa et al. · British Journal of Cancer · 2017 · 96 citations · Full text

Medicine, Molecular Biology, Oncology +17

The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes

Rokaya El Ansari, Madeleine L. Craze, Maria Diez‐Rodriguez et al. · British Journal of Cancer · 2018 · 65 citations · Full text

Medicine, Molecular Biology, Oncology +16

Glutamate dehydrogenase (GLUD1) expression in breast cancer

Madeleine L. Craze, Rokaya El Ansari, Mohammed A. Aleskandarany et al. · Breast Cancer Research and Treatment · 2018 · 62 citations · Full text

Life Sciences, Molecular Biology, Oncology +12